Interleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration*

Torsten WuestefeldDagger, Christian KleinDagger, Konrad L. Streetz, Ulrich Betz, Jörg Lauber§, Jan Buer§, Michael P. Manns, Werner Müller§, and Christian Trautwein||

From the Department of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule Hannover, 30625 Hannover, Germany and § Gesellschaft für Biotechnologische Forschung mbH, 38124 Braunschweig, Germany

Received for publication, August 19, 2002, and in revised form, December 26, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

After tissue loss the liver has the unique capacity to restore its mass by hepatocyte proliferation. Interleukin-6 (IL6)-deficient mice show a lack in DNA synthesis after partial hepatectomy (PH). To define better the role of IL6 and its family members for liver regeneration after PH, we used conditional knockout mice for glycoprotein 130 (gp130), the common signal transducer of all IL6 family members. We show that gp130-dependent pathways control Stat3 activation after PH. By using gene array analysis, we demonstrate that c-jun, NF-kappa B, c-myc, and tumor necrosis factor receptor expression is gp130-dependent. However, in gp130-deleted mice only minor effects on cell cycle and on the maximum of DNA synthesis after PH were found compared with controls. As in conditional gp130 animals, the acute phase response was completely abolished, we considered that other means are essential to define the role of gp130-dependent pathways for liver regeneration. LPS stimulation in gp130-deleted and also IL6 -/- animals after PH leads to a significant reduction in survival and DNA synthesis, which was associated with decreased Bcl-xL expression and higher apoptosis in the liver. These results indicate that the phenotype concerning the reduction in DNA synthesis might be linked to the degree of infection after PH. Thus our results suggest that the role of gp130-dependent signaling is not a direct influence on cell cycle progression after partial hepatectomy but is to activate protective pathways important to enable hepatocyte proliferation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Interleukin 6 (IL6)1 belongs to a family comprising of IL6, IL11, leukemia inhibitory factor, oncostatin M, ciliary neurotropic factor, and cardiotropin 1. They all need the gp130 molecule for signal transduction (1, 2). Knockout mice with deletion of individual cytokines of the IL6 family have a rather mild phenotype (3). Experiments elucidating the role of one specific cytokine of the IL6 family during different pathophysiological conditions are thus hampered by a potential redundancy in activity by another family member. Because all known IL6 family members use gp130 for signal transduction, mice lacking functional gp130 are an attractive model to study the role of IL6-related pathways in vivo.

gp130 knockout mice die in uteri or directly after birth due to myocardial hypoplasia and reduced hemopoiesis in the fetal liver (4, 5). In order to circumvent this problem, conditional gp130 knockout mice using the Cre/loxP system were generated (6). In these mice exon 16 coding for the gp130 transmembrane domain can be deleted as two loxP sites flank it. In animals with the Cre recombinase under the control of the Mx promoter, expression is induced by interferon-alpha or agents triggering internal interferon-alpha expression, e.g. pIpC (6, 7).

In the liver, IL6 is a major regulator of the acute phase response. It has also been shown that IL6 is essential for liver regeneration after partial hepatectomy (PH) (8, 9). First experiments indicated that there is an elevation of TNFalpha followed by IL6 in the serum of animals after PH (8). Further studies using IL6 and TNF receptor 1 (TNF-R1) knockout mice (9, 10) demonstrated that in both knockout animals S phase progression is impaired and some of the animals die after surgery. In both IL6 and TNF-R1 knockout mice, the defect in hepatocyte proliferation can be rescued by treating the animals with IL6. These results imply that the increase in TNFalpha levels is important to induce IL6, which is ultimately involved in triggering liver regeneration (9, 11).

However, other reports indicated the possibility that the role of IL6 on cell cycle progression during liver regeneration after PH is less essential as hypothesized previously (12). These results suggest the possibility that other factors, e.g. the expression of other IL6 family members, may modulate the outcome after PH and raise the question of the ultimate role of IL6 during liver regeneration. In order to circumvent a possible redundancy of different IL6 family members, we used conditional gp130 knockout mice to study liver regeneration after PH. By using this approach, we define more precisely the role of IL6/gp130-dependent signaling, and we show that these pathways may determine survival after PH but not the expression of genes directly involved in cell cycle control.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Mice Strains, pIpC Stimulation, and Southern Blot Experiments-- gp130 loxP (+/+) Mx-Cre (-) mice were bred with gp130 loxP (+/+) Mx-Cre (+) animals. By using this approach, littermates were always homozygote for gp130 loxP and had a 50% chance for the Mx-Cre transgene. These animals with identical backgrounds were then used for further experiments. Cre+ and Cre- (controls) animals were always treated in parallel with pIpC (Sigma) as indicated. 30 µg of isolated genomic DNA derived from mouse livers was digested with EcoRI overnight, separated on a 1% agarose gel, and transferred to Hybond N+ membranes. Membranes were hybridized with a 32P-labeled gp130 probe as described before (6). The deletion efficiency in other organs has already been described (6).

Two IL6 knockout strains and respective controls were used in this analysis (13, 14). The IL6 -/- strain was a gift of Uli Rüther (University of Düsseldorf, Germany) and was back-crossed to a U. S. Naval Medical Research Institute background. The second IL6 -/- strain (C57BL/6) (13) was received from Benhard Schieffer (Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Hannover, Germany).

IL6 Stimulation Experiments and Preparation of Nuclear Extracts-- Gp130 loxP/Mx-Cre-positive (+) and -negative (-) animals were stimulated with 80 µg of pIpC. At different days after stimulation these animals were treated with 10 µg of IL6 per mouse. 3 h after IL6 injection, the liver was harvested, and liver nuclear extracts were prepared as described before (15).

Determination of IL6 Serum Levels-- Enzyme-linked immunosorbent assay using the OptEIA mouse IL6 kit (Pharmingen) measured IL6 serum levels.

Two-thirds Hepatectomy and Preparation of Nuclear Extracts-- 6-8-Week-old male gp130 loxP/Mx-Cre + and - (controls) animals were treated with 80 µg of pIpC per mouse. 10 days after stimulation and 12 h before surgery, food was withdrawn from the animals. Two-thirds (partial) hepatectomy was performed as described earlier (16). The removed median, right, and caudate liver lobes were routinely tested for the efficiency of exon 16 deletion by Southern blot analysis. In all mice the efficiency in the liver was >95%. For LPS stimulation experiments 30 µg of LPS/20 g mouse (Sigma) was injected intraperitoneally 3 h after partial hepatectomy.

For each time point indicated at least 4 mice were used in parallel. Blood was drawn from the animals at each time point. The remaining livers were removed, pooled, and rinsed in ice-cold phosphate-buffered saline, and part of the livers were frozen immediately in liquid nitrogen or tissue-tek (Sakura Europe, Netherlands). The remaining liver was used to prepare nuclear extracts (15).

SDS-PAGE and Western Blot Analysis-- Nuclear extracts were separated on a 10% SDS-polyacrylamide gel and blotted onto a nitrocellulose membrane (Millipore Corp., Bedford, MA) as described previously (15), and Western blot analysis was performed. Membranes were probed with anti-cyclin E and anti-cyclin A as primary antibodies (SC-481, SC-751; Santa Cruz Biotechnology, Santa Cruz, CA). As a secondary antibody, peroxidase-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch, number 711-035-152) was used. The antigen-antibody complexes were visualized using the ECL detection system as recommended by the manufacturer (Amersham Biosciences). Western blot analysis was performed for each protein of interest derived least at three times from different animals.

Gel Retardation Assays-- Gel shift experiments (EMSA) were performed as described previously (15). Liver nuclear extracts were incubated with a 32P-labeled consensus Stat3 (5'-GTG CAT TTC CCG TAA ATC TTG TCT ACA-3') site, AP-1 site (5'-CGC TTG ATG ACT CAG CAG CCG GAA-3'), and NF-kappa B site (5'-AGT TGA GGG GAC TTT CCC AGG G-3') in 1× binding buffer (25 mM HEPES, pH 7.6, 5 mM MgCl2, 34 mM KCl, 2 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, 1 mg/ml poly(dI-dC), 2 mg/ml bovine serum albumin). 3.5 µg of liver nuclear extracts was incubated for 30 min on ice. Free DNA and DNA-protein complexes were resolved on a 4% TBE-polyacrylamide gel. Supershift experiments were performed using anti-Stat1 and anti-Stat3 antibodies (Santa Cruz Biotechnology).

BrdUrd Labeling-- For in vivo pulse-labeling experiments, 5'-bromo-2'-deoxyuridine (BrdUrd, Amersham Biosciences), 30 µg/g mice, was injected intraperitoneally 2 h before killing. Liver tissue was frozen immediately in liquid nitrogen. 5-µm cryosections were fixed in ice-cold acetone/methanol and stained according to the cell proliferation kit manual (Amersham Biosciences).

Northern Blot Analysis-- Northern blot analysis was performed as described previously, according to standard procedures (17). The serum amyloid A, haptoglobin, hemopexin, albumin, c-myc, and beta -actin (GAPDH) cDNA probes were labeled with [alpha -32P]CTP according to the instructions for Rediprime (Amersham Biosciences). The hybridization procedure was performed as described previously (17). Blots were exposed for autoradiography and exposed to an imaging plate (Fuji) for quantification. The specific signals were normalized to the beta -actin signals and set to 1 for untreated animals.

Clontech Gene Array-- For sample preparation for cDNA expression arrays, three livers from each group were homogenized in RNA Clean Solution (HYPAID-AGS) for isolation and purification of total RNA. The RNA was pooled and treated with DNase according to the manufacturer's instructions (Clontech Laboratories, Palo Alto, CA), and the quality of 10 µg of RNA was evaluated by denaturing MOPS gel electrophoresis.

The cDNA probes prepared from DNase-treated RNAs obtained from each of the experimental groups were hybridized simultaneously to four membranes containing Atlas mouse cDNA expression arrays (Clontech). 5 µg of DNase-treated RNA was labeled with [alpha -32P]dCTP and reverse-transcribed to cDNA, according to the manufacturer's protocol. The radioactively labeled cDNA probes were hybridized overnight to cDNA expression arrays using ExpressHyb hybridization solution with continuous agitation at 68 °C. After two high stringency washes, the hybridized membranes were exposed to a PhosphorImaging screen overnight.

The PhosphorImaging results were interpreted by using OptiQuant image analysis software (PerkinElmer Life Sciences). Quantification of each detectable band was performed from the digital light units generated by OptiQuant. The background was subtracted.

TUNEL Assay-- The TUNEL Test (TdT-mediated dUTP nick end labeling) was performed using the "In Situ Cell Death Detection Kit, POD" from Roche Diagnostics according to the instructions of the manufacturer. Sections were analyzed with a fluorescence microscope (Olympus, Hamburg, Germany).

RT-PCR-- RNA was isolated as reported previously (17). First strand synthesis for RT-PCR was performed using oligo(dT)15 primer (Promega) and the Omniscript RT kit (Qiagen) in combination with 1 µg of total RNA per reaction. Amplification of Bcl-xL and GAPDH cDNA was carried out in one reaction using the specific primers (Bcl-xL: sense, 5'-cgacccagccaccacctcctc-3', and antisense, 5'-tgg ggc ctc agt cct att ctc-3', cDNA length 316 bp; GAPDH: sense, 5'-tga tga cat caa gaa ggt ggt gaa g-3', and antisense, 5'-tcc ttg gag gcc atg tag gcc at-3', cDNA length 249 bp) and 1 µl of the RT reaction. Briefly, PCR was performed for 10 cycles with first strand DNA and Bcl-xL primers at a Tanneal of 58 °C. Then the reaction was interrupted; primers for GAPDH were added, and the reaction was continued for another 25 cycles. PCR products were documented and quantitated using a Gel Doc 1000 apparatus (Bio-Rad) and Molecular Analyst software (Bio-Rad). For direct comparison the GAPDH:Bcl-xL ratio was determined.

Quantification-- Quantification of results was performed with a Fuji imager and Pcbas as described earlier (16).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

pIpC Results in Exon 16 Deletion in gp130loxP/Mx-Cre Animals-- pIpC induces interferon-alpha expression in vivo and activates the Mx promoter (7, 18). We injected increasing amounts of pIpC in gp130loxP (+/+)/Mx-Cre (+) animals and gp130loxP (+/+)/Mx-Cre (-) to analyze deletion of gp130 exon 16 in the liver. 72 h after pIpC injection, the liver of the animals was harvested, and DNA was prepared. As evidenced by Southern blot analysis, 20 µg of pIpC resulted in a more than 90% deletion of exon 16 in the gp130 locus in Mx-Cre (+) and not in Mx-Cre (-) animals (data not shown). With 80 µg (Fig. 1A) and higher amounts (160 and 320 µg, data not shown) of pIpC more than 95% of exon 16 was deleted in gp130loxP (+/+)/Mx-Cre (+) animals.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Lack of Stat3 activation in gp130-deleted animals after partial hepatectomy. A, gp130loxP/Mx-Cre + and - animals were stimulated with 80 µg of pIpC/mouse. 10 days after stimulation liver DNA was prepared, and Southern blot analysis was performed. The position of the gp130 loxP (gp130 loxP) and the-deleted gp130 loxP (gp130Delta loxP) signal is indicated. B, IL6 serum levels were determined in gp130 loxP/Mx-Cre + and - animals at the time points (n >4 animals per time point) indicated before and after PH. C, gel shift experiments were performed with liver nuclear extracts (n >4 animals per time point) before and after PH with a 32P-labeled Stat3 consensus oligonucleotide. Gels for gp130 loxP/Mx-Cre + and - animals were run in parallel. The position of Stat3 complex formation is indicated. D, Northern blot analysis was performed including time points before and after PH of gp130 loxP/Mx-Cre - and + mice. Filters were probed with a 32P-labeled cDNA for SOCS-3 and beta -actin (control). The positions of the SOCS-3 and beta -actin signals are indicated.

Next, we tested the functional consequences of a deletion higher than 95% of gp130 exon 16 after 80 µg of pIpC injection in the liver. gp130 loxP (+/+/)/Mx-Cre (+) animals were stimulated with 10 µg of IL6/mouse for 3 h at different days after pIpC treatment. Gel shift analysis with a 32P-labeled Stat3 consensus oligonucleotide showed that IL6-dependent Stat3 complex formation was completely blocked 10 days after pIpC administration (data not shown).

Stat3 Activation Is Blocked in gp130 loxP/Mx-Cre Animals after PH-- Earlier results using IL6 knockout mice implied that IL6 is involved in cell cycle progression after PH (9). We performed partial hepatectomies in conditional gp130 knockout mice. gp130 loxP (+/+)/Mx-Cre (+) (also referred to as gp130-deleted) and gp130 loxP (+/+)/Mx-Cre (-) (controls) animals were both treated with 80 µg of pIpC. After 10 days PH was performed. For each time point indicated at least 4 animals were included, and the efficiency of gp130 exon 16 deletion was monitored by Southern blot analysis in the resected liver lobes. For further analysis only mice were included with a deletion efficiency >95%.

We first measured IL6 serum levels. In both groups IL6 serum levels increased 3 h after PH (Fig. 1B). In controls peak IL6 expression was found after 6 h and in the gp130-deleted group after 12 h. Maximal IL6 levels were more than 2-fold higher in the gp130-deleted group, and at later time points the decrease was slower compared with controls (Fig. 1B). Between the two groups there was no difference in mortality after PH.

EMSA experiments revealed strong Stat3 complex formation 1 h after PH in the control group. At later time points complex formation decreased and returned to background levels (Fig. 1C). In gp130-deleted animals Stat3 activation after PH was completely blocked. No increase in complex formation was found compared with the pretreatment level (Fig. 1C).

Suppressor of cytokine signaling 3 (SOCS-3) is a potent inhibitor of Stat3-dependent gene activation. A recent study by Campbell et al. (19) showed a strong regulation of SOCS-3 during liver regeneration. Therefore, we investigated SOCS-3 mRNA expression in both groups. SOCS-3 transcripts were strongly increased 3 and 6 h (more than 30-fold) after PH in the control group, whereas no regulation was found in gp130-deleted animals (Fig. 1D). No significant regulation was found for SOCS-1 and -2 in both groups after PH (data not shown).

DNA Synthesis after Partial Hepatectomy in gp130-deleted Mice-- gp130-dependent signaling was blocked in gp130-deleted mice after PH. In further experiments we determined the effect on DNA synthesis after PH by BrdUrd pulse-labeling experiments in both groups.

In the control group a maximum of BrdUrd-positive cells was evident 48 h after PH. 39% ± 5 of all hepatocytes were BrdUrd-positive (Fig. 2, A and B). At later time points BrdUrd-positive cells decreased.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 2.   DNA synthesis in gp130-deleted animals after partial hepatectomy. A, BrdUrd staining of liver sections was performed at different time points (n >4 animals per time point) before and after PH in gp130 loxP/Mx-Cre - and + animals. Distinct time points are shown. B, for statistical analysis the amounts of BrdUrd-positive hepatocytes for each point of time are shown per 100 hepatocytes.

In gp130-deleted animals the maximum of BrdUrd-positive cells was observed 48 h after PH and was lower compared with controls. 31% ± 4 nuclei of all hepatocytes were BrdUrd-positive in gp130-deleted animals. At later time points the amount of BrdUrd-positive hepatocytes decreased (Fig. 2, A and B).

Delayed Induction of Cyclins in gp130-deleted Animals-- In further experiments we studied the impact of gp130 deletion on cyclin expression after PH. Cyclin A and E expression was studied by Western blot experiments.

In control animals cyclin E expression was first positive 12 h after PH. There was a continuous increase in cyclin E expression for up to 48 h. At later time points cyclin E expression decreased (Fig. 3A). In gp130-deleted animals, cyclin E was only detected 24 h after PH, and a strong increase was observed up to 48 h after PH. At 72 h cyclin E expression declined (Fig. 3B).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Cyclin E and A expression in gp130-deleted mice after partial hepatectomy. A-D, cyclin E (A and B) and A (C and D) expression was determined in gp130 loxP/Mx-Cre - (A and C) and + (B and D) animals at time points (n >4 animals per time point) before and after PH. An arrowhead shows the position of cyclin E and A. PK, pyruvate kinase.

Cyclin A expression in controls was detected 40 h after PH and decreased thereafter, whereas in gp130-deleted animals cyclin A expression was first positive at the 48-h time point (Fig. 3, C and D).

Gene Array Analysis in gp130-deleted Mice after IL6 Stimulation-- Earlier experiments showed even more pronounced differences in cell cycle progression after hepatectomy in IL6 knockout animals compared with controls (9, 12). Therefore we searched for specific pathways to understand how IL6 may influence cell cycle progression in the liver. We stimulated gp130-deleted and control mice with IL6 for 6 h and prepared mRNA. The mRNAs of untreated and IL6-stimulated animals were used for gene array analysis. The focus of this analysis was on genes that are involved in cell cycle control. This analysis revealed two genes, c-jun and c-myc, that might have an impact on G0/G1 phase transition and are regulated in an IL6-dependent manner in the liver (Fig. 4A). No impact on genes directly involved in cell cycle control-like cyclins was found.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Delayed activation of immediate early genes in gp130-deleted mice after partial hepatectomy. A, gp130 loxP/Mx-Cre - and + mice were included. Animals were stimulated for 6 h (+) with IL6. cDNA array analysis was performed. The impact on cell cycle-related genes is shown. B, basal and IL-6-inducible expression of TNF-R1 and TNF-R2 in control and gp130-deleted animals as evidenced by gene array analysis. C and D, gel shift experiments were performed using liver nuclear extracts derived from gp130 loxP/Mx-Cre - and + before and after PH. 32P-Labeled consensus oligonucleotides for AP1 (C) or NF-kappa B (D) were used in this analysis. Specific complex formation is indicated. EMSA experiments for both groups were performed in parallel.

The gene array analysis showed also a strong effect on the expression pattern of the TNF-R1 and -R2 (Fig. 4B). The gp130-deleted animals are blocked in regulating the TNF-R expression.

Activation of Immediate Early Genes Is Inhibited in gp130-deleted Animals-- In further experiments we tried to specify our gene array data by studying c-myc RNA expression by Northern blot analysis before and after PH. Basal expression and the induction after PH as found in controls were reduced in gp130-deleted animals. Thus gp130-dependent pathways contribute to the basal and inducible c-myc expression after PH (data not shown).

c-Jun is a member of the AP1 complex. Activation after PH was studied by gel shift experiments using a 32P-labeled AP1 consensus oligonucleotide. Strong complex formation was evident 1-36 h after PH in controls. At later time points complex formation decreased and was reduced to pretreatment levels (Fig. 4C). In the gp130-deleted animals specific complex formation was first evident only 36 h after hepatectomy and remained high 48 h after PH (Fig. 4C).

In addition to c-Jun, it has been shown also for NF-kappa B that its activation correlates with liver regeneration after PH (20, 21). In controls, biphasic NF-kappa B activation was evident 1-6 and 24-36 h after PH (Fig. 4D). In gp130-deleted mice the first peak of NF-kappa B activation was strongly reduced, whereas the second peak could be detected equally to controls (Fig. 4D).

Activation of DNA Synthesis after Partial Hepatectomy in IL6 Knockout Animals-- Our experiments in the gp130-deleted animals indicated that gp130-dependent pathways are essential for liver cells in contributing to the activation of distinct immediate early genes as shown previously (9). Because in our experiments the impact on DNA synthesis was less prominent after PH as in IL6 -/- mice (9), we performed partial hepatectomies in IL6 knockout animals (13) and monitored BrdUrd incorporation. DNA synthesis was increased in controls 24 h after PH. Maximal levels were found 48 h after PH. 72 h after PH the amount of BrdUrd-positive cells decreased (Fig. 5, A and B). Compared with controls in IL6 -/- animals the increase and maximum in DNA synthesis was moderately reduced (Fig. 5, A and B).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 5.   DNA synthesis in IL6 knockout animals after partial hepatectomy. A, BrdUrd staining of liver sections was performed at different time points (n = 4 animals per time point) before and after PH in wild type (wt) and IL6 -/- mice. Distinct time points are shown. B, for statistical analysis the amount of BrdUrd-positive hepatocytes for each time point are shown per 100 hepatocytes.

As strain-specific differences may account for changes in hepatocyte proliferation, we additionally performed PHs in a second IL6 -/- strain (14) and stained for BrdUrd-positive cells. These results were consistent with the data obtained in the first IL6 -/- strain (data not shown).

Impaired Acute Phase Gene Regulation in gp130-deleted Animals-- IL6 contributes to acute phase gene expression and represents a first line of defense after bacterial infections (22). Thus after abdominal surgery the outcome may depend upon the ability of the liver to control unspecific defense mechanisms. In further experiments the impact on acute phase gene expression was studied in gp130-deleted mice. As shown in Fig. 6A, serum amyloid A, haptoglobin and hemopexin gene expression were increased starting 3-6 h, and maximal levels were evident 24 h after PH in controls. In contrast, this increase in acute phase gene expression after PH was not found in gp130-deleted mice (Fig. 6A).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 6.   Impaired acute phase gene regulation and LPS injection reduces survival and DNA synthesis in gp130-deleted mice after partial hepatectomy. A, RNA was prepared from mouse liver before and after PH of gp130 loxP/Mx-Cre + and - mice for Northern blot analysis. Filters were probed with 32P-labeled cDNAs for serum amyloid A (SAA), haptoglobin, hemopexin and albumin. As a loading control beta -actin was included in this analysis. B, PH was performed in gp130 loxP/Mx-Cre + mice and controls (n = 13/group). 3 h after PH 30 µg LPS/mouse was injected. Survival of the animals after PH is indicated. C, BrdUrd (BrdU) staining of liver sections was performed 48 h after PH of the gp130 loxP/Mx-Cre - and + mice treated with LPS. For statistical analysis the amount of BrdUrd-positive hepatocytes is shown before and 48 h after PH as positive cells per 100 hepatocytes.

Albumin mRNA expression decreased after PH in the control group (Fig. 6A). In gp130-deleted animals only minor variations in albumin mRNA levels were detected in the first 12 h post-PH (Fig. 6A). These results demonstrate that after PH regulation of the acute phase response is blocked in gp130-deleted animals.

gp130-deleted and IL6 Knockout Animals Are More Vulnerable to LPS after Partial Hepatectomy-- As regulation of the acute phase response was impaired in gp130-deleted animals, we investigated the impact of a bacterial infection, mimicked by LPS injection, on liver regeneration. LPS was injected 3 h after PH, and the impact on survival and DNA synthesis was studied.

LPS-treated, gp130-deleted animals had a significantly worse outcome compared with controls. In the gp130-deleted group 40% of the animals died during the first 48 h after PH. In contrast, the survival rate in controls was 85% after LPS injection (p < 0.01, Fig. 6B).

Higher mortality correlated with a decrease in DNA synthesis in gp130-deleted animals who survived. BrdUrd staining after 48 h revealed an 80% lower rate of BrdUrd-positive hepatocytes in gp130-deleted animals compared with controls (Fig. 6C).

As LPS had a significant effect on survival and DNA synthesis of gp130-deleted animals, we also tested the impact of LPS on survival in IL6 knockout animals compared with controls (Fig. 7A). IL6 -/- animals and controls were treated with LPS 3 h after PH. Survival was evaluated in the first 48 h after PH. In the IL6 -/- animals significantly more animals died after PH (p < 0.05) when they were treated with LPS compared with controls and untreated animals. Thus as found in the gp130-deleted animals, IL6 -/- mice were more susceptible to LPS after PH (Fig. 7A).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   LPS injection leads to reduced DNA synthesis and survival after partial hepatectomy in IL6 knockout mice. A and B, 3 h after PH 30 µg of LPS were injected into wild type controls and IL6 -/- animals (n = 15/group). A, survival of the animals was observed up to 48 h after PH and B, BrdUrd (BrdU)-positive hepatocytes/100 cells were determined at the time points indicated.

These differences were also reflected when BrdUrd staining was performed in the liver of these animals. DNA synthesis 48 h after PH in LPS-treated IL6 -/- mice was significantly reduced compared with controls (Fig. 7B).

Increased Apoptosis in gp130-deleted Animals after Partial Hepatectomy and LPS Stimulation-- The LPS/PH experiments indicated that protective mechanism might be impaired in gp130-deleted animals. Additionally, earlier experiments showed that IL6 might stimulate anti-apoptotic pathways by inducing higher Bcl-xL expression (23). Therefore we studied Bcl-xL expression through an RT-PCR approach early after PH. In control animals we found an increase in Bcl-xL expression 3 h after PH which was not found in gp130-deleted animals (Fig. 8, A and B).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 8.   Lower Bcl-xL expression and higher apoptosis in gp130-deleted animals after partial hepatectomy and LPS stimulation. A, 1 µg of RNA at time points before and after PH of gp130 loxP/Mx-Cre + and - mice were used for cDNA synthesis. Primers for Bcl-xL and GAPDH were used as described under "Materials and Methods" for semi-quantitative duplex PCR. The specific signals of Bcl-xL and GAPDH are indicated. B, the relative Bcl-xL:GAPDH ratio was calculated. The Bcl-xL:GAPDH ratio of untreated animals was set to 1. C, TUNEL assays were performed of liver sections derived from animals 3 h after PH and 6 h after PH stimulated for 3 h with LPS. D, quantitative analysis of TUNEL-positive cells.

As differences in Bcl-xL regulation might be one of the gp130-dependent mechanisms protecting from apoptosis after LPS stimulation, we now studied if there is a difference in the degree of apoptosis between controls and gp130-deleted animals. At the 3-h LPS/6-h PH time point we found a significant increase in apoptosis in the gp130-deleted animals compared with controls (Fig. 8C). In gp130-deleted mice 15-fold more liver cells were TUNEL-positive compared with controls (Fig. 8D).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The molecular mechanisms essential to restore liver mass after injury are complex, and the intra- and extracellular pathways that orchestrate liver regeneration have recently become clearer on a molecular level (11, 24, 25). Earlier experiments showed that after partial hepatectomy there is activation of Stat3 in the first hours after surgery (8, 26). Further experiments using IL6 knockout mice demonstrated that this cytokine is involved in regulating the regenerative response after PH (9). Additionally, TNF-R1 knockout mice showed a lack in liver regeneration that could be rescued by injecting IL6 (10). Based on these data a model has been deducted where first TNFalpha and then IL6 serum levels are increased, and the intracellular pathways that are activated through these two cytokines are essential to trigger cell cycle progression after PH.

In the present study we were interested to examine further the role of IL6 for liver regeneration after partial hepatectomy using conditional gp130 knockout mice. After birth Cre expression in gp130loxP/Mx-Cre animals was induced by pIpC injection. Earlier experiments demonstrated that in these animals efficient deletion of gp130 exon 16 was achieved in the liver and other tissue contributing to the immune response (spleen, bone marrow, thymus) (9). In the liver more than 95% of exon 16 in the gp130 locus was deleted, and IL6-dependent Stat3 activation was inhibited, in contrast to controls. All of the IL6 family members need gp130 for signal transduction, and thus the use of gp130 loxP/Mx-Cre animals circumvents the possibility that other cytokines of this family may compensate for the loss of each other (1, 2).

After PH in hepatocytes of the control group strong Stat3 activation was restricted to the first hours after PH, whereas maximal IL6 serum levels were found after 6 h. Recent experiments published by Fausto and co-workers (19) have revealed a molecular explanation for this observation. They demonstrated that only 1 h after partial hepatectomy SOCS-3 is induced on the mRNA level and reached maximum expression after 2 h. In the present analysis we further characterized this mechanism and showed that SOCS-3 is controlled via gp130-dependent pathways in hepatocytes. Thus, through increasing SOCS-3 expression via gp130, Stat3 activation is strongly restricted after PH.

In our study there is a discrepancy between the relatively early activation of Stat3 after partial hepatectomy and the late peak of IL6 serum expression. As in the gp130-deleted animals no Stat3 DNA binding was found, and activation is likely to be mediated through a gp130-dependent cytokine. Additionally in IL6 -/- animals no Stat3 activation was found after PH (9). These two observations clearly indicate that IL6 induces Stat3 after PH. Therefore it is likely that increased IL6 levels are first present in the liver after PH as the cytokine at this stage may mainly bind to membrane-bound gp80. At later time points, gp80 receptors in the liver are saturated, and increased IL6 levels are present in the serum of the animals. In the serum IL6 is bound to soluble gp80 and soluble gp130 receptors that limit the activation of gp130-dependent pathways also in liver cells. As the pool of soluble gp130 is increased in the gp130-deleted animals, IL6 has a longer half-life in the serum of these animals.

Liver regeneration in gp130-deleted animals showed marked differences compared with controls. Stat3 activation was completely blocked, and gene array analysis defined additional gp130-dependent downstream targets, c-myc and c-jun, after PH. Additionally, our experiments suggest that NF-kappa B activation at the early time points during liver regeneration is gp130-dependent.

The explanation for diminished NF-kappa B and AP1 activation after partial hepatectomy might be caused on different levels. However, our gene array analysis also included TNF-R1 and TNF-R2. Interestingly, the expression of both receptors is controlled via IL6 as in gp130-deleted animals the basal and the inducible expression of TNF-R1 and the inducible expression of TNF-R2 are significantly reduced (Fig. 4B). As NF-kappa B and AP1 are controlled via TNF after PH, these results would explain in part a reduction in the activation of both transcription factors in the gp130-deleted animals after PH.

Our work is in agreement and expands earlier reports of Taub and co-workers (9) and Fausto and co-workers (10) indicating that activation of distinct immediate early genes is dependent on IL6 after PH (9, 10). However, DNA synthesis was reduced in conditional gp130 knockout animals but less severely impaired as described previously in IL6 -/- animals. The increase in cyclin A and E expression was delayed in gp130-deleted animals, which was associated with a minor reduction in DNA synthesis 48 h after PH. Gene array analysis revealed no significant impact of IL6 on genes directly involved in cell cycle control. Similar results were also reported in IL6 -/- mice using gene array analysis after PH (27). Therefore, the gp130-deleted animals could eventually restore liver mass and had no increased mortality compared with controls. Obviously, the observed reduction of immediate early gene activation in gp130-deleted mice implies that in the liver compensatory pathways do exist to induce hepatocyte proliferation.

This result was unexpected. However, further evaluation of the IL6 -/- experiments of Cressmann et al. (9) revealed that they quoted those IL6 -/- animals that survived the follow up after hepatectomy had a normal liver weight 5 days after hepatectomy. These results imply that IL6 is important but not absolutely necessary in order to restore liver mass after PH. Otherwise there would be no obvious explanation that some of the IL6 -/- animals survived and completely restored their liver mass. This hypothesis is further strengthened by the report of Demitris and co-workers (12) using IL6 -/- mice. They demonstrated that in IL6 -/- mice the reduction in DNA synthesis after PH is less severe as originally observed by Cressmann et al. (9) and was comparable with the degree of reduction in DNA synthesis in our present experiments.

In our earlier reports we used a transgenic mouse that overexpressed the soluble IL6 receptor under the control of a hepatocyte-specific control element. In these animals IL6 induces severalfold stronger gp130-dependent signaling in hepatocytes. In contrast to our initial hypothesis, PH and IL6 stimulation did not result in an increase of hepatocyte proliferation but to a delay in cell cycle progression. Thus hyperstimulation of gp130-dependent pathways in hepatocytes was not associated with increased DNA synthesis.

The discrepancy in the results of different groups in the correlation between IL6 and hepatocyte proliferation was obvious. Thus it was difficult to ultimately define the role of IL6 and thus of gp130-dependent signals for liver regeneration. Therefore, we considered other means to explain the role of IL6 for cell cycle progression after PH. Recent studies (23, 28, 29) demonstrated that IL6 induces protective, e.g. anti-apoptotic, pathways in hepatocytes. These results led us to consider the possibility that the role of IL6 in the liver after PH is not mainly to trigger cell cycle progression through immediate early genes but instead is to protect the liver from injury during this complex step. We show in our study that in gp130-deleted animals acute phase gene regulation and thus early defense mechanisms are blocked after PH.

Therefore, to mimic a bacterial infection, we injected LPS in gp130-deleted and control animals after PH. These experiments revealed striking differences in the outcome of these animals similar to the results obtained in the initial PH experiments reported in the IL6 -/- animals (9). After PH DNA synthesis was reduced in the surviving LPS-injected gp130-deleted animals, and the same phenotype was found when LPS was injected into IL6 -/- mice after PH. Consistent with this observation, hepatocyte-specific gp130 knockout animals are also hypersensitive to LPS indicating that gp130-dependent pathways in hepatocytes are essential for this observation (30).

In further experiments we investigated the possible mechanism that might account for higher LPS sensitivity. As in earlier experiments Kovalovich et al. (23) showed that IL6 induces Bcl-xL expression, and we investigated its expression by RT-PCR and found lower expression in the gp130-deleted animals. After PH the finding correlated with a higher rate of apoptosis in the gp130-deleted animals after LPS stimulation indicating that this is most likely an important mechanism that contributes to the worse outcome in these animals after partial hepatectomy and LPS stimulation.

Based on these results we define more specifically the role of the IL6/gp130-dependent pathway during liver regeneration. Higher IL6 expression after PH is important to activate protective pathways that render hepatocytes more resistant toward stress-inducing signals, e.g. bacterial infections after PH. Our results suggest that the phenotype of gp130-deleted and IL6 knockout animals after PH is related to the degree of additional injury. These results would nicely explain why there are differences in the literature upon the strength of the phenotype in IL6 -/- mice after partial hepatectomy.

    FOOTNOTES

* This work was supported by Sonderforschungsbereich 566, Project B08.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Both authors contributed equally to this work.

Present address: Bayer AG, Pharma Research Europe, G. 402, Apratherweg, D-42096 Wuppertal.

|| To whom correspondence should be addressed: Dept. of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. Tel.: 49-511-532-3865; Fax: 49-511-532-4896; E-mail: trautwein.christian@mh-hannover.de.

Published, JBC Papers in Press, December 30, 2002, DOI 10.1074/jbc.M208470200

    ABBREVIATIONS

The abbreviations used are: IL6, interleukin-6; PH, partial hepatectomy; gp130, glycoprotein 130; TNF, tumor necrosis factor; TNF-R, TNF receptor 1; BrdUrd, bromodeoxyuridine; TUNEL, TdT-mediated dUTP nick end labeling; LPS, lipopolysaccharide; RT, reverse transcriptase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; EMSA, electrophoretic mobility shift assay; MOPS, 4-morpholinepropanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Taga, T., and Kishimoto, T. (1997) Annu. Rev. Immunol. 15, 797-819[CrossRef][Medline] [Order article via Infotrieve]
2. Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F., and Graeve, L. (1998) Biochem. J. 334, 297-314[Medline] [Order article via Infotrieve]
3. Ernst, M., Inglese, M., Waring, P., Campbell, I. K., Bao, S., Clay, F. J., Alexander, W. S., Wicks, I. P., Tarlinton, D. M., Novak, U., Heath, J. K., and Dunn, A. R. (2001) J. Exp. Med. 194, 189-204[Abstract/Free Full Text]
4. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K., Wang, W. Z., Mori, C., Shiota, K., Yoshida, N., and Kishimoto, T. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 407-411[Abstract/Free Full Text]
5. Kawasaki, K., Gao, Y. H., Yokose, S., Kaji, Y., Nakamura, T., Suda, T., Yoshida, K., Taga, T., Kishimoto, T., Kataoka, H., Yuasa, T., Norimatsu, H., and Yamaguchi, A. (1997) Endocrinology 138, 4959-4965[Abstract/Free Full Text]
6. Betz, U. A., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Rajewsky, K., and Muller, W. (1998) J. Exp. Med. 188, 1955-1965[Abstract/Free Full Text]
7. Kühn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995) Science 269, 1427-1429[Medline] [Order article via Infotrieve]
8. Trautwein, C., Rakemann, T., Niehof, M., Rose-John, S., and Manns, M. P. (1996) Gastroenterology 110, 1854-1862[Medline] [Order article via Infotrieve]
9. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R. (1996) Science 274, 1379-1383[Abstract/Free Full Text]
10. Yamada, Y., Kirillova, I., Peschon, J. J., and Fausto, N. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1441-1446[Abstract/Free Full Text]
11. Streetz, K. L., Luedde, T., Manns, M. P., and Trautwein, C. (2000) Gut 47, 309-312[Free Full Text]
12. Sakamoto, T., Liu, Z., Murase, N., Ezure, T., Yokomuro, S., Poli, V., and Demetris, A. J. (1999) Hepatology 29, 403-411[Medline] [Order article via Infotrieve]
13. Weinhold, B., and Ruther, U. (1997) Biochem. J. 327, 425-429[Medline] [Order article via Infotrieve]
14. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G. (1994) Nature 368, 339-342[CrossRef][Medline] [Order article via Infotrieve]
15. Trautwein, C., Rakemann, T., Malek, N. P., Plumpe, J., Tiegs, G., and Manns, M. P. (1998) J. Clin. Invest. 101, 1960-1969[Abstract/Free Full Text]
16. Wüstefeld, T., Rakemann, T., Kubicka, S., Manns, M. P., and Trautwein, C. (2000) Hepatology 32, 514-522[Medline] [Order article via Infotrieve]
17. Lüdde, T., Kubicka, S., Plumpe, J., Liedtke, C., Manns, M. P., and Trautwein, C. (2001) Oncogene 20, 5264-5278[CrossRef][Medline] [Order article via Infotrieve]
18. Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., and Poli, V. (2001) Mol. Cell. Biol. 21, 1621-1632[Abstract/Free Full Text]
19. Campbell, J. S., Prichard, L., Schaper, F., Schmitz, J., Stephenson-Famy, A., Rosenfeld, M. E., Argast, G. M., Heinrich, P. C., and Fausto, N. (2001) J. Clin. Invest. 107, 1285-1292[Abstract/Free Full Text]
20. Morello, D., Fitzgerald, M. J., Babinet, C., and Fausto, N. (1990) Mol. Cell. Biol. 10, 3185-3193[Medline] [Order article via Infotrieve]
21. Cressman, D. E., Greenbaum, L. E., Haber, B. A., and Taub, R. (1994) J. Biol. Chem. 269, 30429-30435[Abstract/Free Full Text]
22. Trautwein, C., Böker, K., and Manns, M. P. (1994) Gut 35, 1163-1166[Medline] [Order article via Infotrieve]
23. Kovalovich, K., Li, W., DeAngelis, R., Greenbaum, L. E., Ciliberto, G., and Taub, R. (2001) J. Biol. Chem. 276, 26605-26613[Abstract/Free Full Text]
24. Fausto, N., Laird, A. D., and Webber, E. M. (1995) FASEB J. 9, 1527-1536[Abstract/Free Full Text]
25. Michalopoulos, G. K., and DeFrances, M. C. (1997) Science 276, 60-66[Abstract/Free Full Text]
26. Cressman, D. E., Diamond, R. H., and Taub, R. (1995) Hepatology 21, 1443-1449[Medline] [Order article via Infotrieve]
27. Li, W., Liang, X., Leu, J. I., Kovalovich, K., Ciliberto, G., and Taub, R. (2001) Hepatology 33, 1377-1386[CrossRef][Medline] [Order article via Infotrieve]
28. Galun, E., Zeira, E., Pappo, O., Peters, M., and Rose-John, S. (2000) FASEB J. 14, 1979-1987[Abstract/Free Full Text]
29. Selzner, M., Camargo, C. A., and Clavien, P. A. (1999) Hepatology 30, 469-475[Medline] [Order article via Infotrieve]
30. Streetz, K., Wuestefeld, T., Graw, A., Kamino, K., Tronche, F., Betz, U., Muller, W., Manns, M., and Trautwein, C. (2001) Hepatology 34, 278[CrossRef]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.